Horizon Europe (HorizonEU) offers great opportunities for innovative research and technology development in the Health and Life Science sectors. Following the success of health-related projects funded under Horizon 2020 (2014-2020), the importance of research in this vital field has been highlighted by the impact of COVID-19 on our health care system, economy and society. The pandemic has strongly raised awareness for the urgent need to increase investments in innovative health solutions for the future.
The European Commission points out six health-related challenges in Cluster 1 of HorizonEU’s key strategic orientations:
Research and Innovation supported under Cluster 1 aims to advance knowledge, build capacities as well as design, develop and demonstrate innovative solutions that will improve the health and well-being of European citizens and support the transformation of health care systems.
We at accelopment have been a reliable cooperation partner for numerous research and innovation projects in the health and life science sectors, among diverse other projects.
Together with our excellent consortia, we help monitoring COVID-19 patients in ENVISION, model the development of a bioartifical pancreas in VANGUARD and reduce the high mortality of cardiogenic shock (CGS) patients in EURO SHOCK.
With our experts in EU funding programmes, proposal writing, project management and dissemination, we can complement your research expertise and as a result, together, bring your project further.
Benefit from our strong track record and reduce your workload. We have many years of experience to help you to convey complex contents in a concise and comprehensible way.
| Area | Life Sciences |
| Programme | H2020-SC1-PHE-CORONAVIRUS |
| Duration | 01.12.2020 – 31.07.2022 |
| Budget | 5.6 million euro |
Since 2008, accelopment AG has been located in Zurich, Switzerland. Now we happy to announce that we have crossed the boarder and you can no longer only find us in Zurich but also in Heidelberg, Germany!
Dr. Iana Buch